Abstract:Objective This study aimed to investigate the minimum effective concentration (MEC90, defined as effective in 90% of patients) of ropivacaine during the combined procedure of adductor canal block (ACB) and infiltration between the popliteal artery and capsule of the posterior knee (IPACK) block for patients undergoing total knee arthroplasty. Methods This double-blind, randomized dose-finding trial was based on a biased coin up-and-down sequential design, where the concentration of ropivacaine administered to a given patient depended on the previous patient’s response. Before surgery, the first patient received 20 mL of 0.2% ropivacaine for ACB and again for IPACK. If the block failed, the next subject received a 0.025% higher ropivacaine concentration; otherwise, the next subject received either a 0.025% smaller dose (probability of 0.11) or the same dose (probability of 0.89). The primary outcome was whether the block was successful. Block success was defined as the patient did not suffer significant pain and did not receive rescue analgesia within 6 h after surgery. MEC90 was estimated by isotonic regression, and the 95% confidence interval (CI) was calculated by bootstrapping. Secondary outcomes were numerical rating scale (NRS) pain scores at postoperative 24 h and 48 h, postoperative morphine consumption, and time to hospital discharge. Secondary outcomes were compared between patients whose blocks succeeded with those which failed. Results Based on analysis of 52 patients, the MEC90 was 0.247% (95% CI 0.227–0.271%), MEC95 was 0.260% (95% CI 0.244–0.282%) and MEC99 was 0.272% (95% CI 0.260–0.291%). In contrast, four of nine trials in a recent systematic review reported ropivacaine concentrations below 0.247%. Patients whose blocks succeeded (n = 45) had significantly lower NRS pain scores, lower morphine consumption, and shorter hospitalization than patients whose blocks failed (n = 7). Conclusions Our small trial suggests that 0.247% ropivacaine in 20 mL respectively can provide successful ACB + IPACK block in 90% of patients. However, given that many published trials have used lower concentrations, our findings should be verified in larger studies.

Pharmacokinetics of different concentration of ropivacaine following lumbar plexus combined with sciatic nerve block

Application of ropivacaine for combined spinal-epidural labor analgesia

Clinical Application of Lumbar Plexus Block Technique on Intertrochanteric Fractures Surgery

Lumbar plexus combined sciatic nerve block with ropivacaine with different concentrations

Effects of a fixed low-dose ropivacaine with different volume and concentrations on interscalene brachial plexus block: a randomized controlled trial

Comparision of Pharmacokinetics Between Ropivacaine Methanesulfonate and Ropivacaine Hydrochloride During Epidural Block

Systemic Ropivacaine Concentrations Following Local Infiltration Analgesia and Femoral Nerve Block in Older Patients Undergoing Total Knee Arthroplasty

The Median Effective Analgesic Concentration of Ropivacaine in Sciatic Nerve Block Guided by Ultrasound After Arthroscopic Anterior Cruciate Ligament Reconstruction: A Double-Blind Up-Down Concentration-Finding Study

Comparison of Different Concentrations of Ropivacaine Used for Ultrasound-Guided Adductor Canal Block + IPACK Block in Total Knee Arthroplasty.

The Clinic Test of 0.75% Ropivacaine Used in Combined Spinal-Epidural Block for Renal Transplation Operation

Different Concentrations of Ropivacaine under Ultrasound Guidance on Quadratus Lumbar Muscle Nerve Block in Elderly Patients with Hip Replacement

Effects of varying concentrations of ropivacaine on pain relief in ultrasound-guided brachial plexus block surgery in the intercostal space

Pharmacokinetics and LC-MS/MS method of blood concentration of ropivacaine in surgical patients

Minimum Effective Concentration of Ropivacaine for Ultrasound-Guided Adductor Canal + IPACK Block in Total Knee Arthroplasty

Clinical study of lumbar plexus/sciatic nerve block using peripheral nerve stimulator and epidural anesthesia in the lower extremity surgery in elderly patients

Comparison of ropivacaine and bupivacaine for intrathecal anesthesia during outpatient arthroscopic surgery

Effect of 20% Lipid Emulsion on Pharmacokinetics of 0.5% Ropivacaine after Interscalene Nerve Block in Patients Undergoing Upper Limb Orthopacdic Surgery

Determination of ECs0 of ropivacaine for postoperative analgesia under general anesthesia combined with single interscalene brachial plexus block

Comparison of efficacy of ropivacaine and bupivacaine for spinal anesthesia in patients undergoing unilateral lower limb surgery:a prospective,multicenter,randomized,double-blind study

Pharmacokinettcs of epidural ropivacaine methylsuifonate in patients undergoing lower abdominal surgery

A Comparison of 0.5% Ropivacaine and 1% Mepivacaine for Sciatic Nerve Block in the Popliteal Fossa